Thumbnails similares a AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD

20 vecinos (thumb_512) · 105 views · HCPLive · Estados Unidos


★	AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD	HCPLive @hcplivenews	105	Estados Unidos
12	Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD \| ATS 2026	HCPLive @hcplivenews	301	Estados Unidos	66
11	Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation	HCPLive @hcplivenews	217	Estados Unidos	66
1	Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD	HCPLive @hcplivenews	198	Estados Unidos	82
15	William Feldman, MD: Azithromycin Over Roflumilast in Real World COPD Data	HCPLive @hcplivenews	182	Estados Unidos	65
8	Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD	HCPLive @hcplivenews	152	Estados Unidos	66
10	New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results	HCPLive @hcplivenews	151	Estados Unidos	66
2	Total Plaque Volume Indicates Patients With 0 CAC May Still be at Risk	HCPLive @hcplivenews	120	Estados Unidos	68
16	What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis?	HCPLive @hcplivenews	92	Estados Unidos	65
7	Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD	HCPLive @hcplivenews	88	Estados Unidos	67
6	Omalizumab vs Oral Immunotherapy for Multifood Allergy	HCPLive @hcplivenews	65	Estados Unidos	67
17	ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis	HCPLive @hcplivenews	58	Estados Unidos	65
19	Implications of the Phase 4 Trial of Metreleptin in Patients With General Lipodystrophy	HCPLive @hcplivenews	55	Estados Unidos	65
4	SGLT2 Inhibitors May Reduce COPD Readmissions I ATS 2026	HCPLive @hcplivenews	48	Estados Unidos	67
13	Lifestyle, Pharmacologic Therapies, and EXCEL Trial Data Reshape MASLD Treatment Framework	HCPLive @hcplivenews	48	Estados Unidos	66
9	POCUS is Standard of Care in Critical Care, With Rhea Votipka, NP	HCPLive @hcplivenews	35	Estados Unidos	66
20	FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines	HCPLive @hcplivenews	33	Estados Unidos	64
5	Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients \| ATS 2026 \| Gerald Criner, MD	HCPLive @hcplivenews	29	Estados Unidos	67
3	How ABCG2 Inhibition Could Change EPP Disease Management	HCPLive @hcplivenews	17	Estados Unidos	68
14	Trials and Guidelines Shaping Critical Care, With Rhea Votipka, NP	HCPLive @hcplivenews	17	Estados Unidos	65
18	Diabetes Increases Mortality Risk Across All Major Organ Transplants	HCPLive @hcplivenews	12	Estados Unidos	65